Best Practice & Research Clinical Haematology
Volume 20, Issue 1 , Pages 5-12, March 2007

The chronic myeloproliferative disorders and mutation of JAK2: Dameshek's 54 year old speculation comes of age

  • Kenneth Kaushansky, MD (Professor and Chair)

      Affiliations

    • Corresponding Author InformationTel.: +1 619 543 2259; Fax: +1 619 543 3931.

Department of Medicine, Division of Hematology/Oncology, University of California, San Diego, 402 Dickinson Street, Suite 380, CA 92103-8811, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(06)00085-5

doi:10.1016/j.beha.2006.11.005

Best Practice & Research Clinical Haematology
Volume 20, Issue 1 , Pages 5-12, March 2007

Article Tools

* Image Usage & Resolution